Companies included in the HealthShares(TM) Cardiology Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of cardiological indications including, but not limited to, atherosclerosis, coronary artery disease, congestive heart failure, stroke, hypertension, thrombosis, and restenosis.
Companies included in the HealthShares(TM) Neuroscience Index are engaged in the research, clinical development and/or commercialization of therapeutic agents for the treatment of a wide variety of neurological and psychiatric disorders including, but not limited to, Alzheimer's, Parkinson's, Huntington's, schizophrenia, anxiety, depression, epilepsy, pain and sleep disorders.
Mergent, Inc., a Xinhua Finance company (TSE Mothers: 9399; OTC ADRs: XHFNY), is the preferred provider of business and financial data on global publicly listed companies. Headquartered in Fort Mill, SC and New York City with sales offices in key North American cities, Mergent also has a strong global presence with offices in London, Shanghai, Tokyo, Toronto and Sydney. Mergent's databases contain detailed equity, debt and corporate action information on over 15,000 U.S. public companies, 20,000 non-U.S. public companies and all U.S. municipal bonds.
For more than a century, Mergent has been providing solutions to
clients in the investment management, academic, research and corporate
information fields. Today, that unique experience is combined with
leading-edge technology to form a robust, diverse product line that
operates under Mergent's umbrella. These include Mergent's Dividend
Achievers Indices -- the premier benchmark for long-term returns; Ford
Equity Research -- a leading independent investment research firm; Mergent
Online -- a powerful web-based research portal that provides critical
business information to support daily research and analysis; Mergent
|SOURCE Mergent, Inc.|
Copyright©2008 PR Newswire.
All rights reserved